...
search icon
adag-img

Adagene Inc Share Price

ADAG
NMQ
$3.25
+$0.4
(14.04%)
1D
Industry: Biotechnology Sector: Health Care

Adagene Inc Analyst Forecast

Adagene Inc Share Price Chart

Adagene Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$134.32M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
133.79K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.73
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.3 L
$3.19 H
$3.25

About Adagene Inc, Common Stock

Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People's Republic of China. Its lead product candidate is the ADG126, a masked fully-human anti-CTLA-4 mAb which is in phase 1b/2 clinical development for the treatment of cancer. The company also develops ADG116, a fully human anti-CTLA-4 antibody generated using NEObody technology, which is in phase 1b/2 clinical trials to treat advanced/metastatic solid tumors; ADG206, which is in phase 1 clinical development to treat advanced metastatic solid tumors; ADG104, anti-PD-L1 monoclonal antibody which is in phase 2 clinical development; and ADG125, a novel anti-CSF-1R mAb which is in Phase 2 clinical development. In addition, it is developing ADG138, a HER2xCD3 POWERbody which is in pre clinical trial to treat low expressing tumors, as well as resistant/refractory tumors; ADG152, a CD20xCD3 POWERbody which is in preclincal trial to treat off-tumor toxicities; ADG153, a masked anti-CD47 IgG1 SAFEbody, wihx is in preclinical trial for the treatment of hematologic and solid tumor; and CD28 T-cell engagers, an anti-CD28 bispecific POWERbody TCEs to treat solid tumors. The company was incorporated in 2011 and is headquartered in Suzhou, China. more

Industry: BiotechnologySector: Health Care

Adagene Inc Stock Returns

Time FrameADAGSectorS&P500
1-Week Return8.37%-1.08%-1.38%
1-Month Return67.65%-0.47%-1.81%
3-Month Return58.33%2.13%1.38%
6-Month Return72.73%17.04%5.68%
1-Year Return57.46%6.56%11.74%
3-Year Return51.6%16.78%65.15%
5-Year Return-88.85%34.34%73.68%
10-Year Return-90.5%137.88%260.03%

Adagene Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue480.00K10.18M9.29M18.11M103.20K[{"date":"2020-12-31","value":2.65,"profit":true},{"date":"2021-12-31","value":56.18,"profit":true},{"date":"2022-12-31","value":51.31,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":0.57,"profit":true}]
Cost of Revenue----926.25K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit480.00K10.18M9.29M18.11M(823.04K)[{"date":"2020-12-31","value":2.65,"profit":true},{"date":"2021-12-31","value":56.18,"profit":true},{"date":"2022-12-31","value":51.31,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-4.54,"profit":false}]
Gross Margin100.00%100.00%100.00%100.00%(797.49%)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-797.49,"profit":false}]
Operating Expenses19.65M82.54M93.21M41.83M36.05M[{"date":"2020-12-31","value":21.08,"profit":true},{"date":"2021-12-31","value":88.55,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":44.88,"profit":true},{"date":"2024-12-31","value":38.68,"profit":true}]
Operating Income(19.17M)(72.36M)(83.92M)(23.72M)(35.95M)[{"date":"2020-12-31","value":-1916965000,"profit":false},{"date":"2021-12-31","value":-7236408900,"profit":false},{"date":"2022-12-31","value":-8392068300,"profit":false},{"date":"2023-12-31","value":-2371986600,"profit":false},{"date":"2024-12-31","value":-3595154300,"profit":false}]
Total Non-Operating Income/Expense1.54M600.17K4.09M9.64M5.46M[{"date":"2020-12-31","value":15.96,"profit":true},{"date":"2021-12-31","value":6.23,"profit":true},{"date":"2022-12-31","value":42.45,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":56.63,"profit":true}]
Pre-Tax Income(16.43M)(71.48M)(79.51M)(17.25M)(33.44M)[{"date":"2020-12-31","value":-1643230800,"profit":false},{"date":"2021-12-31","value":-7147632200,"profit":false},{"date":"2022-12-31","value":-7951279200,"profit":false},{"date":"2023-12-31","value":-1725496200,"profit":false},{"date":"2024-12-31","value":-3344166400,"profit":false}]
Income Taxes3.16K1.70M459.06K1.69M(17.55K)[{"date":"2020-12-31","value":0.19,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":26.98,"profit":true},{"date":"2023-12-31","value":99.4,"profit":true},{"date":"2024-12-31","value":-1.03,"profit":false}]
Income After Taxes(16.44M)(73.18M)(79.97M)(18.95M)(33.42M)[{"date":"2020-12-31","value":-1643547200,"profit":false},{"date":"2021-12-31","value":-7317793500,"profit":false},{"date":"2022-12-31","value":-7997184700,"profit":false},{"date":"2023-12-31","value":-1894637000,"profit":false},{"date":"2024-12-31","value":-3342411100,"profit":false}]
Income From Continuous Operations(16.43M)(73.18M)(79.97M)(18.95M)(33.42M)[{"date":"2020-12-31","value":-1643230800,"profit":false},{"date":"2021-12-31","value":-7317793500,"profit":false},{"date":"2022-12-31","value":-7997184700,"profit":false},{"date":"2023-12-31","value":-1894637000,"profit":false},{"date":"2024-12-31","value":-3342411100,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(16.44M)(73.18M)(79.97M)(18.95M)(33.42M)[{"date":"2020-12-31","value":-1643547200,"profit":false},{"date":"2021-12-31","value":-7317793500,"profit":false},{"date":"2022-12-31","value":-7997184700,"profit":false},{"date":"2023-12-31","value":-1894637000,"profit":false},{"date":"2024-12-31","value":-3342411100,"profit":false}]
EPS (Diluted)(3.20)(1.95)(3.21)(2.55)(0.57)[{"date":"2020-12-31","value":-320.41,"profit":false},{"date":"2021-12-31","value":-195,"profit":false},{"date":"2022-12-31","value":-321,"profit":false},{"date":"2023-12-31","value":-255,"profit":false},{"date":"2024-12-31","value":-57.5,"profit":false}]

Adagene Inc Ratios

Adagene Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

ADAG
Cash Ratio 2.20
Current Ratio 2.29

Adagene Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ADAG
ROA (LTM) -24.89%
ROE (LTM) -63.26%

Adagene Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ADAG
Debt Ratio Lower is generally better. Negative is bad. 0.43
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.57

Adagene Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ADAG
Trailing PE NM
Forward PE NM
P/S (TTM) 1301.54
P/B 3.51
Price/FCF NM
EV/R 745.44
EV/Ebitda 1.12

FAQs

What is Adagene Inc share price today?

Adagene Inc (ADAG) share price today is $3.25

Can Indians buy Adagene Inc shares?

Yes, Indians can buy shares of Adagene Inc (ADAG) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ADAG stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Adagene Inc be purchased?

Yes, you can purchase fractional shares of Adagene Inc (ADAG) via the Vested app. You can start investing in Adagene Inc (ADAG) with a minimum investment of $1.

How to invest in Adagene Inc shares from India?

You can invest in shares of Adagene Inc (ADAG) via Vested in three simple steps:

  • Click on Sign Up or Invest in ADAG stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Adagene Inc shares
What is Adagene Inc 52-week high and low stock price?

The 52-week high price of Adagene Inc (ADAG) is $3.19. The 52-week low price of Adagene Inc (ADAG) is $1.3.

What is Adagene Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Adagene Inc (ADAG) is

What is Adagene Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Adagene Inc (ADAG) is 3.51

What is Adagene Inc dividend yield?

The dividend yield of Adagene Inc (ADAG) is 0.00%

What is the Market Cap of Adagene Inc?

The market capitalization of Adagene Inc (ADAG) is $134.32M

What is Adagene Inc's stock symbol?

The stock symbol (or ticker) of Adagene Inc is ADAG

How Can Investors Use Adagene Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Adagene Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Adagene Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Adagene Inc shares for Indian investors?

When investing in Adagene Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Adagene Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Adagene Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Adagene Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Adagene Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top